Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Wnt signaling pathway activating non-coding RNA (WSPAR, also called lncTCF7, among other aliases) is a long non-coding RNA that promotes activation of the canonical Wnt signaling pathway, often by regulating the expression or enhancer activity of TCF7—a major transcription factor in Wnt signaling. WSPAR/lncTCF7 is involved in maintaining stemness features in certain cell types, including cancer cells, and exercises regulatory control over gene expression both at the chromatin and transcriptional level. While not a traditional protein receptor or enzyme, WSPAR is increasingly considered a non-traditional therapeutic target due to its pivotal regulatory role in disease and stem cell biology. The exact molecular mechanism, druggability, and disease roles remain an area of ongoing research. Although WSPAR is best characterized in oncology contexts, its full biological and clinical significance is still being explored.
Regulation of transcriptional complexes in the Wnt pathway; Molecular scaffolding for chromatin modification; Modulation of neighboring and distant gene expression via cis and trans mechanisms
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Wnt signaling pathway activating non-coding RNA (WSPAR).